batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. US knocks back another Chinese PD-1 entrant 17 May 2024 ESMO Breast Cancer 2024 – Arvinas rises as vepdegestrant stays the same 16 May 2024 Astra holds its own in stage III lung cancer 13 May 2024 Gilead and Arcellx Immagine the future 10 May 2024 iTeos’s TIGIT enters Arcus territory 10 May 2024 Keynote-B21 checks Keytruda’s endometrial advance 9 May 2024 2seventy bets the house on an Abecma renaissance 9 May 2024 Another Zynlonta shift? 8 May 2024 Load More